Skip to main content
. 2016 Sep 7;7(41):67435–67448. doi: 10.18632/oncotarget.11883

Figure 1. Concurrent and mutually exclusive mutations in NMIBC patients at diagnosis.

Figure 1

A. and stratified according to grade B., risk C., or recurrence D.